chrisvoncsefalvay/vaers-outcomes huggingface dataset:
11/17 She broke out in hives and rashes. Was given Benadryl cream for 2 days and after the rash seemed to reverse and come back in increasing time and severity. 11/19 saw Pediatrician about rash and hives. After a physical exam it was determined to be a viral situation like chicken pox. Was advised to continue Zyrtec and Hydrocortisone cream. Will see pediatrician in a month if shows no signs of clearing up. Ongoing issue.
I woke up with a sore throat, headache and sneezing. My husband had already tested positive. I was losing my voice and was very tired so I tested on July 1st and was positive. I was sick for about 5 days with the sore throat and headache coming and going. I had virtual healthcare visit with my doctor and they recommended mixing TYLENOL and MOTRIN. I declined taking PAXLOVID as I was not compromised and my case was relatively mild. I tested negative on the 13th. The fatigue lasted for a while but I would say I am completely recovered from myself. For 2 weeks I felt not myself and I didn't have much energy. The other symptoms started to wain after the first week.
Mild headache the day of injection. Moderate nausea and overall malaise on day 1 after  injection. Mild nausea, overall malaise, mild fatigue on day 2 after injection.
Patient had left facial paresthesias, left arm paresthesias within 24 hours and b/l blurry vision with headache 72 hours after the vaccination that lasted at least 48 hours. Negative workup for CVA, recurrent cancer or thrombus.
This spontaneous prospective pregnancy report as received from a nurse refers to a female patient of unknown age. On 27-OCT-2041, a 27 weeks pregnant patient was vaccinated with M-M-R II (dose, route not reported), (lot # reported as J00200, expiration date 01-SEP-2014). Last Menstrual Period of 21-APR-2014 and Estimated Date of Delivery of 26-JAN-2015. The patient sought medical attention and did not receive any treatment for the event. At the time of the report the pregnancy outcome was pending. Additional information has been requested.
Information has been received from a registered nurse concerning a 15 year old female who on 10/10/00, was inadvertently vaccinated with two doses of Hepatitis B vaccine. One dose of 10 mcq in the deltoid and one dose of 5 mcq  in the deltoid. This was given as a first dose series by mistake. After the second injection, the patient fainted. On 10/10/00, the patient recovered.
(1) Swelling; Itching a sight 10-12-12. (2) Circle the size of Lemon at site of injection today 10-17-12. (3) Pins/needles to touch - 10-12-12 at site.
pt recvd 2nd dose of pedvaxHIB on 9DEC91 & devel a local rxn that persisted for several wks; On 31DEC91 the pt presented to MD who examined a red, swollen, tender nodule on pts rt thigh; green pus was aspirated; gram stain showed gram pos;
I had chest congestion and coughing for almost six weeks. It wasn't relieved with any over the counter medication. I went to the doctor on January 11, 2023. I was sent for a chest x-ray. It was clear. I was given an antibiotic, albuterol inhaler, and a Z-PAK. It took about a week to get over my symptoms.
Patient received moderna vaccine on 3/8/21, 4/5/21 and 11/22/21. COVID positive on 2/14/22. Patient admitted at an outside hospital on 2/14/22. She worsened with hypoxia and intubated. Transferred to this hospital on 3/6/22.  Was on antibiotics that were broad-spectrum and underwent pancultures.  Was also found early in the hospitalization have a left-sided pleural effusion and underwent thoracentesis with significant improvement of continued dyspnea.  Had an acute anemia on chronic and also pancytopenia.  Required transfusion and after transfusion of packed red blood cells hemoglobin remained stable.  Was started on Neupogen as well.  She has MDS and AML as noted above.  Chemotherapy was on hold until current issues were resolved.  Hematology followed in the hospital.  Was continued on home blood pressure medications and blood pressure and heart rate remained stable throughout her hospitalization.  Oxygen titrated for best affect.  Was found positive in her inflammatory exudate for S per kilos this.  Was started on voriconazole at loading dose and then to have a course of 12 weeks of treatment.  Was continued on vancomycin and Zosyn to completion.  Doxycycline was 100 mg b.i.d. as well for 7 days and then back to suppressive dose per Oncology.  Continued with generalized improvement in terms of her exercise capacity.  Physical therapy and occupational therapy followed and cleared patient to return home with family help. Discharged on 3/17/22
No adverse event; Doses were given 21 days apart; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Doses were given 21 days apart) and NO ADVERSE EVENT (No adverse event) in a 4-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. AS1412B and AS1414B) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jul-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Aug-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Aug-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Doses were given 21 days apart). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Doses were given 21 days apart) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Doses were given 21 days apart).    No concomitant product use was provided.  The patient has not experienced any symptoms. No additional doses, medications, or treatments have been administered at this point in time.
Stroke like symptoms; Couldn't speak; Shortness of breath; Legs and arm weakness; Dizziness with Nystagmus; Throat swelling; Dizziness with vertigo; Dizziness with vertigo; A spontaneous report was received from a nurse concerning a 79-year-old, white, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced stroke like symptoms, dizziness with nystagmus, legs and arm weakness, couldn't speak, shortness of breath, throat swelling and  dizziness with vertigo.  The patient's medical history, as provided by the reporter included anemia, overactive bladder, fibroid cystic disease, allergy to fluoroquinolone, ciprofloxacin, povidone iodine, morphine and adhesive tape. The concomitant medications reported included atorvastatin, calcium, colecalciferol, metoprolol succinate, pramipexole hcl and prasugrel hcl for unspecified indications.  On 07 Jan 2021, 11 hours prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 025J20-2A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. The patient experienced stroke like symptoms, couldn't speak, shortness of breath and throat swelling. It was reported that the patient was hospitalized for acute stroke.  On an unknown date, while still being hospitalized, the patient developed, dizziness with nystagmus and dizziness with vertigo. The lab findings included, magnetic resonance imaging (MRI) and computed tomography (CT) scans as negative for acute findings, electrocardiography (EKG), complete blood count (CBC), X-ray and chemistries were reported as within normal limits. The patient remained hospitalized for 2.5 days while the symptoms improved.  On 09 Jan 2021, the patient was discharged.  On 20 Jan 2021, the reporter stated that the patient felt weak and tired without other symptoms. It was also noted that the patient's discharge summary stated the patient's symptoms may be worse following a second dose of mRNA-1273 vaccine.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events, stroke like symptoms, dizziness with nystagmus, legs and arm weakness, couldn't speak, shortness of breath, throat swelling and  dizziness with vertigo. were considered as resolved on an unknown date.; Reporter's Comments: This case concerns a 79-year-old, white, female patient with medical history of anemia, overactive bladder, fibroid cystic disease, who experienced the serious, unexpected event of stroke, Aphasia,  dyspnea and non-serious, unexpected events of , dizziness, vertigo, pharyngeal swelling, nystagmus and muscular weakness. The events of stroke, Aphasia, Dyspnea and pharyngeal swelling occurred 11 hours after the first dose of  mRNA-1273 (Lot number: 025J20-2A) administration and the events of dizziness, vertigo, pharyngeal swelling, nystagmus and muscular weakness occurred on an unknown date while the patient was still hospitalized. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Loss of balance, stutter step, involuntary rocking when standing, occasional rocking when sitting
Patient had pain at injection site day of and afterwards. This throbbing pain has continued till this date.
10 minutes after vaccination, Patient began to slouch and shake - her face tone (pale) also became extremely white. She became light headed and had to lay down - pulse remained strong and consistent. She did not lose consciousness but needed to lie down for 15 minutes and drink 3 Gatorades to regain strength to sit upright without feeling lightheaded.
Pt requested to receive COVID vaccine. Phizer first dose was given as recommended. The next day when staff was inputting data in computer for insurance, it was denied because pt had already received Johnson and Johnson vaccine at another facility on April 11, 2021. Staff called insurance to verify and then called patient to verify. They both stated, yes patient had previously received the J&J COVID vaccine. Patient was told he could not receive the second dose of Pfizer. Patient did not notify Rite Aid staff nor immunizer that he had previously received the J&J vaccine.
Since i had my second shot of Moderna in my left arm, i had the deep pain in my left arm down to my  left arm and hand and fingers.  Mostly my left side is the affected side. Started having left foot pain in my sole and toes. After a day, i had muscle pains and my left knee became very stiffed that ended wrapping my left knee with ace bandage all the time.  Three days ago... i had this excruciating pain in my back that i have to  use a back brace.
Information has been received from a nurse concerning a 65 year old female who on 20-APR-2009 was vaccinated with a 0.5 ml dose of PNEUMOVAX. On 24-APR-2009 the patient the patient came into the office because she had redness and swelling in the injection site which site was of a silver dollar. The nurse reported that the physician believed that the experience could be cellulitis. The nurse reported that the patient was doing better. Additional information has been requested.
This spontaneous report as received from a nurse practitioner refers to a 25 year old female patient. Patient's pertinent medical history and concomitant medication was reported as none. The patient is currently not pregnant at this time of report. Patient's drug reactions/allergies included penicillin and ZITHROMAX. On an unknown date in June 2015, the patient received PREVNAR 13 (manufacturer unknown), (dose, route, indication, lot number and expiration date unknown). On an unknown date in June 2015, after receiving PREVNAR 13 (manufacturer unknown) the patient developed "soreness in her arm" and she "couldn't lift her arm without pain." On 23-AUG-2015, the patient was vaccinated with PNEUMOVAX23 (dose, route, lot number and expiration date unknown). On 23-AUG-2015, after receiving PNEUMOVAX23, within "2 hours" the patient complained of "aches, pains, tingling in the hands, hives and intense pain on the left arm" to the physician. The patient had sought medical attention and was prescribed with prednisone as treatment for the events. The nurse reported that the patient had visited the office twice, on unspecified dates, for follow-up appointments since she received the PNEUMOVAX23 and that while "some of the effects have subsided" she continues to experience "myalgia, decreased memory and lower back pain" at this time of report. Lab test: unspecified "blood work" (unknown date): result and units not provided. The outcome of the adverse events was reported as not recovered (also reported as some of the effects have subsided). Additional information has been requested.
Pt recvd vax & exp nausea, sl dizziness & pain over liver & epigastric area; sx persisted for eight hrs; No further details were provided;
Heart palpitations, couldn?t sleep even with a sleeping pill,.. took a couple of hours
first, out sick from work for 2 days after the shot: headaches, body aches, low fever...now, I have been diagnosed by MD with an 'arthritis' reaction to the H1N1 shot. Had mild osteoarthritis before, now have severe bodywide arthritis, especially in hands and hips.
COLD SWEATING; NOT ABLE TO EAT; VOMITING; FEVER; NAUSEA; HEADACHE; MUSCLE ACHE; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination.  The batch number was not reported and has been requested.  No concomitant medications were reported. On APR-2021, the subject experienced cold sweating. On APR-2021, the subject experienced not able to eat. On APR-2021, the subject experienced vomiting.  On APR-2021, the subject experienced fever. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced muscle ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, cold sweating, nausea, headache, muscle ache, not able to eat and vomiting was not reported. This report was non-serious.
Per patient report, was seen in ER on 05/26/2010 here at clinic for follow up on 06/03/2010 for vaccine reaction.  Pt upper arm had localized erythema and swelling.  No axillary or clavicular node palpated.  Recommended he continue antihistamine daily for 7 days past arm clearing.
Patient presented for flu vaccination at work site. Nurse reviewed front of form and read the patient's age as 66 instead of 60.  Nurse did not review back of form which had additional check for patient's age.  She offered the high dose to the patient which he accepted.  Reviewed with nurse workflow to avoid future error like this. She stated understanding. F/U call made to patient on 9/13 to explain what happened.  He understands and did not have any questions.
Patient received Moderna booster dose. He received the 22nd dose out of the vial. It was later found out that the vial is only supposed to be punctured a max of 20 times. Patient has reported no adverse events.
This spontaneous report was received from a pharmacist via company representative and refers to a 12-year-old female patient. There was no information about patient's concomitant medications and pertinent medical history reported. In June 2015, the patient was vaccinated with a dose of VARIVAX reconstituted with the sterile diluent, (dose, route, anatomical location, lot number and expiration date were not reported for both suspects therapies) for prophylaxis. In June 2016, the patient presented to the pharmacy having herpes zoster described as developed shingles (twelve months after received the VARIVAX which was administered at unspecified pediatrician's office). At the time of the report, the patient recovered from the herpes zoster on an unspecified date. The relatedness between the event and therapy with VARIVAX was not reported. Additional information has been requested.
Muscle ache, fever, chills, muscle weakness, spasms in muscles, stomach pain for a short period followed by nauseous, severe headache.
Welts all over body. Prednisolone and BENADRYL sent to the pharmacy.
Pt tested negative using antigen test on 4/16/21 upon admission to emergency room; Pt requested to receive moderna vaccine on 4/20/21  (family signed consent). Pt was screened for s/s of covid prior to administration of vaccine on 4/20/21. Vital signs were within normal limits and temp was 97.5. Pt started having covid related symptoms on 4/21/21 late afternoon ( fever 102 f, congestion and change in mental status). Pt was sent out via EMS to local hospital for evaluation. Covid test was performed with positive results noted.
On 12/28/2022, onset of cough and fever to 101. Severe fatigue. Fever lasted a week. Cough persisted for six weeks. I saw my primary five days after onset and had chest X-ray. We thought it was RSV.
Stiff neck developed same day within 12 hours, knot has come up on neck which is extremely sore.  Have tried cold compresses, hot compresses, and Tylenol, and nothing has affected it.  It is now Wednesday evening and it is still just as sore.
None after 1st shot.  After 2nd:  Felt crummy all next day. Then that went away and felt ok again. Didn't eat but did drink fluids that day. No Alcohol or drugs or tobacco. The next day I woke up with severe muscle aches in hamstrings, shoulders, arms, back. This stayed until Saturday that week. Was very discouraged, fatigued and immobile. I was going to call for appt on Monday. I remembered I had 7 days worth of a Prednisone perscription that I hadn't needed to take in the fall of 2020. So I took 2- 20mg pills once a day for 7 days. After just a few hours of the first dose, I felt somewhat better and that continued quickly relieving the pain and stiffness and fatigue.
72 years old patient received Menveo; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 72-year-old patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.  Additional details were provided as follows: Health care professional reported that the 72 years old patient received Menveo, which led to inappropriate age at vaccine administration. No adverse event were detected after vaccination. No patient's or vaccine identifiers were reported. Health care professional provided little details to first line agent and wanted to get contacted by mail with medical information on this matter. The reporter consented to follow up.
Patient went into the vaccine appointment perfectly healthy and thriving.  Since the day after (November 17, 2021) Patient has suffered from:  Extreme Fatigue Muscle Soreness in arms and legs Brain Fog Breathlessness with only minor exertion Low white blood cell count Slow heart beat Irregular heart rhythm
Administered Rt. Deltoid 1/27/10. 1/28/10 pt presented with red bumps, heat, pain at injection site as well as back of Rt. arm "hives".
Fever 105.7, difficulty breathing, lethargy  Treated at home, Tylenol, advil, rest
T-100.0 Painful to move her arm.  Pain in all of arm and neck. Unable to move. Site tender to touch and hot. Painful with extension.
Weakness in left hand. Unable to grasp or straighten fingers.  MRI performed at the emergency room, showed TIA or mini-stroke.  Standard medications for stroke were administered. Admitted to the hospital overnight and monitored. Hand weakness resolved within a couple of hours from onset. Discharge orders were aspirin, Plavix, Lipitor, heart monitor and sleep study. As of today, there is no clear cause.
DTaP KINRIX was given to the patient instead of DTaP PEDIARIX in addition to the polio immunization. Patient showed no adverse effects from the injection.
Patient called at 6:15 PM reporting rapid heart rate and numbess/tingling on the left side of their face. Patient reported these symptoms began at around 6:00 PM.Patient reported HR as high as 125 BPM but then said it had decreased to 70-90 BPM by the time they had called. Patient was then instructed to report to a ER/Urgent care just to be safe which she agreed to do.
Information has been receive from a physician concerning a female in her 30's with a history of 2 previous prregnancies with 2 live births who on approximately 9/25/01 was vaccinated with a third dose of MMR II. The pt received vaccination at the time of last menstrual period (LMP approximately 9/25/01). It was reported that the pt was vaccinated with a second dose of MMR II. On 10/30/01, the pt found out that she was pregnant. The estimated date of delivery was determined to be 7/2/02. The pt took prenatal vitamins and had no infections or illnesses during her pregnancy. The pt underwent multiple ultrasounds which were normal. It was reported that the pt was placed on bedrest for early cervical dilatation. On 6/27/02, at 39 weeks from LMP, the pt delivered a normal female infant weighing 7lb 0oz. The infant had no complications or congential anomalies. No additional info is expected.
Positive SARS-CoV-2 RNA test. Admitted to inpatient with Covid symptoms shortness of breath and dry cough. Remdesivir started to 9/17, planning for 5 days course.
Patient was inadvertently and incorrectly administered a moderna dose when she had received the Pfizer dose on 2/8/21. I counseled her based on CDC recommendations and told her she would not need any further doses of either vaccine. I further counseled patient to report any adverse events immediately to myself or her PCP. I will continue to check in with patient to monitor her progress.
Information has been received from Pfizer, Inc and was assigned manufacturer number 2010137550/11710635, concerning a patient who on an unknown date was vaccinated with a dose of MMR II (lot n. not reported). Caller reported that the patient experienced an "odd reaction" to MMR II. It is unknown if the patient sought medical attention. At the time of reporting the patient's outcome was unknown. This was originally reported by a nurse. No further information is available.
Extreme swelling, burning, itching, soreness, difficulty with moving arm, fever, fatigue,